Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
We performed a retrospective analysis of the European Group for Blood and Marrow Transplantation database comparing the outcomes of multiple myeloma patients who received tandem autologous followed by allogeneic PSCT (auto-allo) with the outcomes of patients who underwent a reduced intensity conditi...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
23 March 2015
|
| In: |
Bone marrow transplantation
Year: 2015, Jahrgang: 50, Heft: 6, Pages: 802-807 |
| ISSN: | 1476-5365 |
| DOI: | 10.1038/bmt.2015.45 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1038/bmt.2015.45 Verlag, Volltext: http://www.nature.com/bmt/journal/v50/n6/full/bmt201545a.html 
|
| Verfasserangaben: | F Sahebi, S Iacobelli, AV Biezen, L Volin, P Dreger, M Michallet, PT Ljungman, T de Witte, A Henseler, NPM Schaap, L López-Corral, X Poire, J Passweg, R-M Hamljadi, SH Thomas, S Schonland, G Gahrton, C Morris, N Kröger and L Garderet on behalf of the Plasma Cell Disorders Subcommittee of the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancies Working Party |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1556270089 | ||
| 003 | DE-627 | ||
| 005 | 20220813154707.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170404s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/bmt.2015.45 |2 doi | |
| 035 | |a (DE-627)1556270089 | ||
| 035 | |a (DE-576)486270084 | ||
| 035 | |a (DE-599)BSZ486270084 | ||
| 035 | |a (OCoLC)1340969280 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sahebi, Firoozeh |e VerfasserIn |0 (DE-588)1129200388 |0 (DE-627)88384415X |0 (DE-576)486268586 |4 aut | |
| 245 | 1 | 0 | |a Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma |c F Sahebi, S Iacobelli, AV Biezen, L Volin, P Dreger, M Michallet, PT Ljungman, T de Witte, A Henseler, NPM Schaap, L López-Corral, X Poire, J Passweg, R-M Hamljadi, SH Thomas, S Schonland, G Gahrton, C Morris, N Kröger and L Garderet on behalf of the Plasma Cell Disorders Subcommittee of the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancies Working Party |
| 264 | 1 | |c 23 March 2015 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.04.2017 | ||
| 520 | |a We performed a retrospective analysis of the European Group for Blood and Marrow Transplantation database comparing the outcomes of multiple myeloma patients who received tandem autologous followed by allogeneic PSCT (auto-allo) with the outcomes of patients who underwent a reduced intensity conditioning allograft (early RIC) without prior autologous transplant. From 1996 to 2013, we identified a total of 690 patients: 517 patients were planned to receive auto-allo and 173 received an early RIC allograft without prior autologous transplant. With a median follow-up of 93 months, 5-year PFS survival was significantly better in the auto-allo group, 34% compared with 22% in the early RIC group (P<0.001). OS was also significantly improved in the auto-allo group with a 5-year rate of 59% vs 42% in the early RIC group (P=0.001). The non-relapse mortality rate was lower in the auto-allo group than in the early RIC group, with 1- and 3-year rates of 8% and 13% vs 20% and 28%, respectively (P<0.001). The relapse/progression rate was similar in the two groups, with 5-year rates of 50% for auto-allo and 46% for early RIC (P=0.42). These data suggest that planned tandem autologous allograft can improve overall survival compared with upfront RIC allograft alone in patients with multiple myeloma. | ||
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bone marrow transplantation |d London : Springer Nature, 1997 |g 50(2015), 6, Seite 802-807 |h Online-Ressource |w (DE-627)320433366 |w (DE-600)2004030-1 |w (DE-576)091012996 |x 1476-5365 |7 nnas |a Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma |
| 773 | 1 | 8 | |g volume:50 |g year:2015 |g number:6 |g pages:802-807 |g extent:6 |a Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/bmt.2015.45 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.nature.com/bmt/journal/v50/n6/full/bmt201545a.html |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170404 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 60000 |d 61400 |e 60000PS122405226 |e 61400PS122405226 |k 0/60000/ |k 1/60000/61400/ |p 16 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 60000 |d 61400 |e 60000PD1028891881 |e 61400PD1028891881 |k 0/60000/ |k 1/60000/61400/ |p 5 | ||
| 999 | |a KXP-PPN1556270089 |e 2963911041 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1556270089","relHost":[{"part":{"extent":"6","volume":"50","text":"50(2015), 6, Seite 802-807","issue":"6","year":"2015","pages":"802-807"},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myelomaBone marrow transplantation","title":[{"title_sort":"Bone marrow transplantation","title":"Bone marrow transplantation"}],"origin":[{"dateIssuedDisp":"1997-","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke ; London"}],"note":["Gesehen am 17.01.25"],"pubHistory":["Nachgewiesen 19.1997 -"],"id":{"zdb":["2004030-1"],"issn":["1476-5365"],"eki":["320433366"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320433366"}],"physDesc":[{"extent":"6 S."}],"name":{"displayForm":["F Sahebi, S Iacobelli, AV Biezen, L Volin, P Dreger, M Michallet, PT Ljungman, T de Witte, A Henseler, NPM Schaap, L López-Corral, X Poire, J Passweg, R-M Hamljadi, SH Thomas, S Schonland, G Gahrton, C Morris, N Kröger and L Garderet on behalf of the Plasma Cell Disorders Subcommittee of the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancies Working Party"]},"id":{"eki":["1556270089"],"doi":["10.1038/bmt.2015.45"]},"title":[{"title":"Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma","title_sort":"Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma"}],"note":["Gesehen am 04.04.2017"],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"23 March 2015"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"family":"Sahebi","display":"Sahebi, Firoozeh","role":"aut","given":"Firoozeh"},{"display":"Dreger, Peter","family":"Dreger","role":"aut","given":"Peter"},{"family":"Schönland","display":"Schönland, Stefan","given":"Stefan","role":"aut"}]} | ||
| SRT | |a SAHEBIFIROCOMPARISON2320 | ||